BioTuesdays: OnPoint’s Big-Data Equals Big Opportunity
April 16, 2013 by leonardzehr · Leave a Comment
OnPoint Medical Diagnostics (OTCQB:ONMD) is pioneering a “big-data” platform for delivering measurable, objective and automated quality assurance (QA) solutions for magnetic resonance imaging (MRI), with plans to expand its framework to include other modalities such as computed tomography (CT), ultrasound and mammography. The company was founded in 2010 to commercialize imaging QA technologies developed by Mayo Clinic, where testing began in 2006.
“We estimate there is a $6 billion global market opportunity for imaging QA and informatics,” president and CEO, William Cavanaugh, says in an interview with BioTuesdays. “Right now, with MRI, our competition is pencil and paper, three-ring binders and the fax machine, so we see this as a blue ocean opportunity.”
A big-data solution objectively measures each individual imaging scan and compares it against an internal standard or an industry benchmark......
See BioTuesdays site for the rest of this feature article.